摘要
Purpose: This research aims to explore the therapeutic effect of Zuogui Pills on knee osteoarthritis through experimental and clinical research on rat knee osteoarthritis under the guidance of TCM theory and modern scientific research methods. After establishing the animal KOA model, Zuogui Pills was used for animal experiment intervention. After 6 weeks of experiment, the serum IL-1β, TNF-a and the cartilage tissue p38 MAPK, JNK, ERK1/2 phosphorylation protein expression levels of experimental animals were detected. The data is processed using statistical methods, Deeply explore the effective mechanism of the drug for KOA, provide a theoretical basis for its clinical application, and provide new ideas for clinical treatment of KOA. Methods: Eighty healthy male rats with a weight of 200-250g were randomly divided into 4 groups, namely A normal group, B blank control group, C diacerein western medicine group, and D Zuogui pills experimental group. Group A did not do any treatment, and the other three groups of experimental mice used the modified Hulth method to establish KOA models, that is, the rats were approached through the medial knee joint, cut off the medial collateral ligament and anterior cruciate ligament, and removed the medial meniscus.200,000 U of penicillin was injected intramuscularly for 3 days after operation to prevent infection. After the surgical wound healed, the rats were forced to move for 0.5h every day for 2 weeks. After 2 weeks of forced exercise, the rat’s knee joint underwent MRI examination. The joint gap was widened, the medial meniscus was absent, the articular cartilage surface was not flat, the cartilage layer became thin, local defects, connective tissue hyperplasia, osteophyte formation, and joint swelling. The solution was obvious, and the rat KOA model was successfully established. The experimental intervention was started on the first day after the model was successfully established. The intragastric administration was administered for 6 weeks, one course of treatment was 2 weeks, and the interval between each course was 2 days. The blank control group and the normal group were given 10mL/(kg·d) 0.9% NaCl solution by gavage; the western medicine group was given 2.340mg/(kg·d) diacerein by gavage; the treatment group was given 4.6g/(kg·d) Zuogui pills are given by gavage. After 6 weeks of the experiment, the rats in each group were fasted with water for 12 hours, and the rats in each group were anesthetized with 10% chloral hydrate solution by intraperitoneal injection of 0.3mL·100g-1. After the rat's righting reflex disappeared and the tail-tip pain disappeared, blood was collected by abdominal aorta puncture, centrifuged at 3500 r·min-1 for 15 min, and the upper serum was aspirated, and stored in a low temperature refrigerator at -80°C for later use. After blood is taken from the abdominal aorta, it is cut from the upper and lower knee joints, and the knee joint of the right hind limb is taken. All the muscle tissue is removed and the knee joint tissue is completely exposed. After the treatment is completed, it is immersed in 4% paraformaldehyde solution for fixation. ELISA method was used to detect the levels of IL-1β and TNF-a in rat serum, and Western Blot method was used to detect the expression levels of p38 MAPK, JNK, ERK1/2 phosphorylated proteins. Results: ⑴ IL-1β expression level: After the intervention, the serum IL-1β content of each group of rats was compared in pairs. The blank control group, diacerein western medicine group, and Zuogui pills experimental group were significantly higher than the normal group (P <0.01); Diacerein western medicine group and Zuogui pills experimental group were significantly lower than the blank control group (P<0.01).⑵ TNF-a expression level: After the intervention, the serum TNF-a content in each group of rats was compared in pairs. The blank control group, diacerein western medicine group, and Zuogui pills experimental group were significantly higher than normal (P< 0.01); Diacerein western medicine group and Zuogui pills experimental group were significantly lower than the blank control group (P<0.01), and Zuogui pills experimental group was lower than diacerein western medicine group (P<0.05).Table 1Comparison of serum IL-1β and TNF-a levels in each group after the intervention(x ±s)GroupNumber (only)IL-1β(pg/ml)TNF-a(pg/ml)Group A2030.86±1.6514.81±2.35Group B20104.76±3.9856.30±5.61Group C2050.36±3.0140.01±2.87Group D2047.84±5.5634.09±3.04Note: Comparison of serum IL-1β and TNF-a levels in groups A and B p<0.01; comparison of serum IL-1β and TNF-a levels in groups A and C p<0.01; serum IL-1β and TNF-a in groups A and D Comparison of content p<0.01; Comparison of serum IL-1β and TNF-a levels of B and C groups p<0.01; Comparison of serum IL-1β and TNF-a levels of B and D groups p<0.01; Serum IL-1β of C and D groups The content comparison p>0.05; the serum TNF-a content comparison of C and D groups p<0.05.⑶ The expression of p38 MAPK, JNK, ERK1/2 phosphorylated protein in cartilage tissue in the blank control group, diacerein western medicine group and Zuogui pills experimental group was significantly higher than that in the normal group (P<0.01); diacerein The expression of the western medicine group and the Zuogui pills experimental group was significantly lower than that of the blank control group (P<0.01); and the expression of phosphorylated protein in the Zuogui pills experimental group was significantly lower than that of the diacerein western medicine group (P<0.01). Open table in a new tab Table 2The expression levels of p38 MAPK, JNK, ERK1/2 phosphorylated proteins in cartilage tissues of rats in each group(x ±s)Groupp-p38 MAPK/GAPDHp-JNK/GAPDHP-ERK1/2/GAPDHGroup A0.350±0.0530.550±0.0300.601±0.034Group B0.953±0.0311.304±0.0611.403±0.039Group C0.765±0.0261.085±0.0301.065±0.024Group D0.611±0.0320.653±0.0410.765±0.043Note: Comparison of the expression levels of p38 MAPK, JNK, ERK1/2 phosphorylated protein in cartilage tissues of A, B, A, C, A, D groups p<0.01; p38 MAPK, JNK, ERK1 in cartilage tissues of B, C, B, and D groups /2 phosphorylated protein expression level comparison p<0.01; C and D group cartilage tissue p38 MAPK, JNK, ERK1/2 phosphorylated protein expression level comparison p<0.01. Open table in a new tab Note: Comparison of serum IL-1β and TNF-a levels in groups A and B p<0.01; comparison of serum IL-1β and TNF-a levels in groups A and C p<0.01; serum IL-1β and TNF-a in groups A and D Comparison of content p<0.01; Comparison of serum IL-1β and TNF-a levels of B and C groups p<0.01; Comparison of serum IL-1β and TNF-a levels of B and D groups p<0.01; Serum IL-1β of C and D groups The content comparison p>0.05; the serum TNF-a content comparison of C and D groups p<0.05.⑶ The expression of p38 MAPK, JNK, ERK1/2 phosphorylated protein in cartilage tissue in the blank control group, diacerein western medicine group and Zuogui pills experimental group was significantly higher than that in the normal group (P<0.01); diacerein The expression of the western medicine group and the Zuogui pills experimental group was significantly lower than that of the blank control group (P<0.01); and the expression of phosphorylated protein in the Zuogui pills experimental group was significantly lower than that of the diacerein western medicine group (P<0.01). Note: Comparison of the expression levels of p38 MAPK, JNK, ERK1/2 phosphorylated protein in cartilage tissues of A, B, A, C, A, D groups p<0.01; p38 MAPK, JNK, ERK1 in cartilage tissues of B, C, B, and D groups /2 phosphorylated protein expression level comparison p<0.01; C and D group cartilage tissue p38 MAPK, JNK, ERK1/2 phosphorylated protein expression level comparison p<0.01. Conclusions: (1) Zuogui Pills has a significant inhibitory effect on the expression of IL-1β and TNF-a. (2) The p38 MAPK, JNK, and ERK1/2 signaling pathways have a high degree of coordination in the pathogenesis of K0A, and their abnormal activation causes devastating damage to cartilage. (3) The mechanism of Zuogui Pills in treating KOA may be related to the inhibition of the activation of p38 MAPK, JNK, ERK1/2 signaling pathways.